Emcure Pharmaceuticals Share Price
Know More₹1,515.95 32.50 (2.19%)
04:01 PM, 6-Feb-2026₹1,515.70 33.40 (2.25%)
03:45 PM, 6-Feb-2026BSE : 544210
NSE : EMCURE
Sector : Health care
ISIN Code : INE168P01015
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 06-Feb-2026 | 09:31 PM IST
| Market Cap (₹ Cr.) | 28,738 |
Traded Value (₹ Cr) | 0.79 |
Volume (Shares) | 5,211 |
Face Value (₹) | 10 |
52-Week High (₹) | 1,585.50 |
52-Week High Date | 19-Jan-2026 |
52-Week Low (₹) | 890.00 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 1,585.50 |
All Time High Date | 19-Jan-2026 |
All Time Low (₹) | 890.00 |
All Time Low Date | 07-Apr-2025 |
Emcure Pharmaceuticals Ltd
Emcure Pharmaceuticals Ltd News
Emcure Pharma Announcement
Appointment of Ms. Amruta Jana Yangalwar as Company Secretary and Compliance Officer of the Company.
Emcure Pharmaceuticals Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr.) | 28,733 |
| EPS - TTM (₹) [C] | 47.20 |
| P/E Ratio (X) [C] | 32.11 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 30.00 |
| Latest Dividend Date | 14-Aug-2025 |
| Dividend Yield (%) | 0.20 |
| Book Value Share (₹) [C] | 250.17 |
| P/B Ratio (₹) [C] | 6.06 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| UTI-Healthcare Fund (IDCW) | 10.98 | 75,000 | 1.04 |
| UTI-Healthcare Fund (G) | 10.98 | 75,000 | 1.04 |
| UTI-Healthcare Fund - Direct (G) | 10.98 | 75,000 | 1.04 |
| UTI-Healthcare Fund - Direct (IDCW) | 10.98 | 75,000 | 1.04 |
Research Reports
Stock Strength
| Today's Low/High (₹) | 1,461.10 1,520.00 |
| Week Low/High (₹) | 1,422.20 1,554.00 |
| Month Low/High (₹) | 1,410.00 1,586.00 |
| Year Low/High (₹) | 889.00 1,586.00 |
| All time Low/High (₹) | 890.00 1,586.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 3.50% | 3.55% | 1.59% | 1.47% |
| 1 Month | -0.71% | -0.80% | -1.74% | -1.85% |
| 3 Month | 14.36% | 14.42% | 0.15% | 0.38% |
| 6 Month | 6.65% | 6.57% | 3.77% | 4.56% |
| 1 Year | 17.86% | 17.93% | 7.07% | 8.86% |
| 3 Year | - | - | 38.13% | 44.63% |
Company Info
Company Information
Whole Time Director : MUKUND KESHAO GURJAR
Whole Time Director : SUNIL RAJNIKANT MEHTA
Managing Director & Chief Executive Officer : SATISH RAMANLAL MEHTA
Chairman (Non-Executive) : Berjis M Desai
Whole Time Director : NAMITA VIKAS THAPAR
Independent Director : P S Jayakumar
Independent Director : Vijay Gokhale
Independent Director : Vidya Rajiv Yeravdekar
Independent Director : Shailesh Ayyangar
Whole-time Director : SAMIT SATISH MEHTA
Registered Office: Plot # P-1 & P-2 IT BT Park, Phase II MIDC Hinjawadi,Pune,Maharashtra-411057 Ph: +91 20 3507 0033/+91 20 3507 0000
Email:investors@emcure.com
FAQs about Emcure Pharmaceuticals Ltd
1. What's the Emcure Pharmaceuticals Ltd share price today?
Emcure Pharmaceuticals Ltd share price was Rs 1,515.95 at 04:01 PM IST on 6th Feb 2026. Emcure Pharmaceuticals Ltd share price was up by 2.19% over the previous closing price of Rs 1,483.45. Emcure Pharmaceuticals Ltd share price trend:
- Last 1 Month: Emcure Pharmaceuticals Ltd share price moved down by 0.71% on BSE.
- Last 3 Months: Emcure Pharmaceuticals Ltd share price moved up by 14.36% on BSE.
- Last 12 Months: Emcure Pharmaceuticals Ltd share price moved up by 17.86% on BSE.
2. How can I quickly analyse the performance of the Emcure Pharmaceuticals Ltd stock?
The performance of the Emcure Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 32.11
- Price to book value ratio is 6.06
- Dividend yield of 0.20
- The EPS (trailing 12 months) of the Emcure Pharmaceuticals Ltd stock is Rs 47.20
3. What is the market cap of Emcure Pharmaceuticals Ltd?
Emcure Pharmaceuticals Ltd has a market capitalisation of Rs 28,738 crore.
4. What is Emcure Pharmaceuticals Ltd's 52-week high/low share price?
The Emcure Pharmaceuticals Ltd’s 52-week high share price is Rs 1,585.50 and 52-week low share price is Rs 890.00.
5. Is the Emcure Pharmaceuticals Ltd profitable?
On a consolidated basis, Emcure Pharmaceuticals Ltd reported a profit of Rs 231.37 crore on a total income of Rs 2,365.33 crore for the quarter ended 2025. For the year ended 2025, Emcure Pharmaceuticals Ltd had posted a profit of Rs 707.47 crore on a total income of Rs 7,896.00 crore.
6. Which are Emcure Pharmaceuticals Ltd’s peers in the Health care sector?
Emcure Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Ajanta Pharma, Gland Pharma, J B Chemicals &, Emcure Pharma, Wockhardt, Astrazeneca Phar, Piramal Pharma.
7. Who owns how much in Emcure Pharmaceuticals Ltd?
Key changes to the Emcure Pharmaceuticals Ltd shareholding are as follows:
- Promoter holding in Emcure Pharmaceuticals Ltd has gone down to 77.88 per cent as of Dec 2025 from 77.92 per cent as of Mar 2025.
